Press Releases Year None20242023202220212020201920182017201620152014 Oct 24, 2024 Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024 Keep Reading Oct 22, 2024 Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash Keep Reading Oct 15, 2024 Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer Keep Reading Sep 12, 2024 Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance Keep Reading Sep 09, 2024 Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels Keep Reading Aug 27, 2024 Twist Bioscience to Present at Baird Global Healthcare Conference 2024 Keep Reading Aug 08, 2024 Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb Keep Reading Aug 06, 2024 Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Keep Reading Aug 05, 2024 Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis Keep Reading Aug 02, 2024 Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results Keep Reading Current page 1 Page 2 Page 3 Page 4 Next page next › Last page last » Print Page Email Page Email Alerts RSS Feeds
Year None20242023202220212020201920182017201620152014 Oct 24, 2024 Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024 Keep Reading Oct 22, 2024 Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash Keep Reading Oct 15, 2024 Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer Keep Reading Sep 12, 2024 Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance Keep Reading Sep 09, 2024 Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels Keep Reading Aug 27, 2024 Twist Bioscience to Present at Baird Global Healthcare Conference 2024 Keep Reading Aug 08, 2024 Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb Keep Reading Aug 06, 2024 Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Keep Reading Aug 05, 2024 Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis Keep Reading Aug 02, 2024 Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results Keep Reading Current page 1 Page 2 Page 3 Page 4 Next page next › Last page last »
Oct 24, 2024 Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024 Keep Reading
Oct 22, 2024 Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash Keep Reading
Sep 12, 2024 Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance Keep Reading
Sep 09, 2024 Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels Keep Reading
Aug 08, 2024 Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb Keep Reading
Aug 06, 2024 Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Keep Reading
Aug 05, 2024 Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis Keep Reading